Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-24 7:04 pm Sale |
2024-09-20 | 13D | Vapotherm, Inc. VAPO |
Perceptive Advisors LLC | 1,000 100.000% |
-2,011,999 (-99.95%) |
Filing History |
| 2024-09-23 5:42 pm Purchase |
2024-09-12 | 13G | Praxis Precision Medicines, Inc. PRAX |
Perceptive Advisors LLC | 1,119,035 6.300% |
1,119,035 (New Position) |
Filing History |
| 2024-08-15 6:31 pm Sale |
2024-08-14 | 13D | Lyra Therapeutics, Inc. LYRA |
Perceptive Advisors LLC | 12,757,562 19.500% |
-1 (-0.00%) |
Filing History |
| 2024-08-14 7:21 pm Purchase |
2024-08-12 | 13D | MeiraGTx Holdings plc MGTX |
Perceptive Advisors LLC | 12,696,562 16.400% |
1,254,000 (+10.96%) |
Filing History |
| 2024-07-29 9:43 pm Purchase |
2024-07-17 | 13G | Verona Pharma plc VRNA |
Perceptive Advisors LLC | 5,118,145 6.300% |
1,251,931 (+32.38%) |
Filing History |
| 2024-07-17 4:32 pm Purchase |
2024-07-11 | 13G | Orchestra BioMed Holdings, Inc. OBIO |
Perceptive Advisors LLC | 4,592,556 12.800% |
2,160,467 (+88.83%) |
Filing History |
| 2024-06-25 8:16 pm Purchase |
2024-06-17 | 13D | Vapotherm, Inc. VAPO |
Perceptive Advisors LLC | 2,012,999 32.400% |
2,012,999 (New Position) |
Filing History |
| 2024-06-06 8:37 pm Purchase |
2024-05-30 | 13D | Immatics N.V. IMTX |
Perceptive Advisors LLC | 8,170,846 7.900% |
8,170,846 (New Position) |
Filing History |
| 2024-05-13 5:06 pm Purchase |
2024-04-09 | 13G | Biodesix, Inc. BDSX |
Perceptive Advisors LLC | 6,673,880 5.600% |
6,673,880 (New Position) |
Filing History |
| 2024-05-01 4:57 pm Purchase |
2024-04-30 | 13D | Trinity Biotech plc TRIB |
Perceptive Advisors LLC | 56,000,000 26.800% |
56,000,000 (New Position) |
Filing History |
| 2024-04-17 4:16 pm Sale |
2024-04-16 | 13D | VBI VACCINES INC CDA COM VBIVQ |
Perceptive Advisors LLC | 1,261,710 4.400% |
-119,645 (-8.66%) |
Filing History |
| 2024-04-17 4:15 pm Purchase |
2024-04-15 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
Perceptive Advisors LLC | 5,143,575 8.300% |
1,874,996 (+57.36%) |
Filing History |
| 2024-04-15 4:20 pm Purchase |
2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM |
Perceptive Advisors LLC | 1,566,669 8.500% |
1,566,669 (New Position) |
Filing History |
| 2024-04-15 08:21 am Purchase |
2024-04-11 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Perceptive Advisors LLC | 5,360,858 17.400% |
2,353,000 (+78.23%) |
Filing History |
| 2024-04-10 4:50 pm Purchase |
2024-03-24 | 13D | Landos Biopharma, Inc. LABP |
Perceptive Advisors LLC | 1,486,991 47.700% |
1,486,991 (New Position) |
Filing History |
| 2024-04-03 6:18 pm Unchanged |
2024-04-01 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
Perceptive Advisors LLC | 3,268,579 5.400% |
0 (Unchanged) |
Filing History |
| 2024-03-20 5:51 pm Purchase |
2024-03-13 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
Perceptive Advisors LLC | 3,268,579 5.400% |
8,566 (+0.26%) |
Filing History |
| 2024-03-14 4:13 pm Purchase |
2024-03-05 | 13G | Precision BioSciences, Inc. DTIL |
Perceptive Advisors LLC | 500,000 7.900% |
500,000 (New Position) |
Filing History |
| 2024-03-11 5:45 pm Purchase |
2024-02-28 | 13G | Artivion, Inc. AORT |
Perceptive Advisors LLC | 2,383,978 5.800% |
2,383,978 (New Position) |
Filing History |
| 2024-03-06 4:15 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Perceptive Advisors LLC | 0 0.000% |
-2,099,952 (Position Closed) |
Filing History |